Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_assertion type Assertion NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_head.
- NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_assertion description "[Ex vivo MTX sensitivity of lymphoblasts obtained from pediatric patients with acute lymphoblastic leukemia (ALL; n = 157) was determined by the in situ thymidylate synthase inhibition assay after either continuous (21 hours; TSI(50, cont)) or short-term (3 hours; TSI(50, short)) MTX exposure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_provenance.
- NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_assertion evidence source_evidence_literature NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_provenance.
- NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_assertion SIO_000772 15797993 NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_provenance.
- NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_assertion wasDerivedFrom gad-20130706 NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_provenance.
- NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_assertion wasGeneratedBy ECO_0000203 NP63353.RAwL7t5VcYPZZJGrFYJsV3z6nC3W09hiN9DIS6c6TxHRg130_provenance.